Faron Pharmaceuticals

Virtual drug company

Synergistics technologies

Drug candidates

News
Faron's extraordinary shareholders' meeting invites Dr. Risto Lammintausta to join Faron Board
FARON INITIATES PHASE I/II CLINICAL TRIAL IN UK TO TREAT ACUTE LUNG INJURY
US patent office has granted CLEVER-1 patent to Faron
TEKES FINANCES FARON'S ALI (Acute Lung Injury) PROGRAM WITH EUR 1.2 MILLION

Faron is a virtual drug company focusing to discovery and development of proprietary new compounds/use for:

 

• vasculopathies

• traumas

• inflammation

• metastasis